Search results: Sage Journals

Free accessResearch articleFirst published January, 2018

Poly-de-prescribing to treat polypharmacy: efficacy and safety

Doron Garfinkel

Therapeutic Advances in Drug Safety

Restricted accessReview articleFirst published April, 2024

De-Prescribing Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease: A Narrative Review

Michelle N. Schroeder, Hailee M. Sens, Shaina K. Shah

Journal of Pharmacy Practice

Restricted accessResearch articleFirst published August, 2019

Use of antipsychotics and benzodiazepines for dementia: Time for action? What will be required before global de-prescribing?

Stephen J Ralph, Anthony J Espinet

Dementia

Open accessResearch articleFirst published December, 2019

Polypharmacy among community-dwelling elderly in Singapore: Prevalence,risk factors and association with medication non-adherence

Yi Wen Tan, Sumithra Suppiah, Mary Ann C Bautista [...]

Proceedings of Singapore Healthcare

Restricted accessResearch articleFirst published May, 2020

Pharmacovigilance in Hospice/Palliative Care: De-Prescribing Combination Controlled Release Oxycodone-Naloxone

Katherine Clark, Paul G. Byrne, Jane Hunt [...]

Journal of Palliative Medicine

Open accessResearch articleFirst published 2022

De-Prescribing Proton Pump Inhibitors in Patients With End Stage Kidney Disease: A Quality Improvement Project

Daniel Czikk, Yasin Parpia, Katelyn Roberts [...]

Canadian Journal of Kidney Health and Disease

Open accessResearch articleFirst published October, 2020

The Role of the Medical School Training on Physician Opioid Prescribing Practices: Evidence from Ontario,Canada: Le rôle de la formation à la faculté de médecine à l’égard des pratiques de prescription d’opioïdes des médecins: données probantes d’Ontario,Canada

Claire de Oliveira, Tomisin Iwajomo, Tara Gomes [...]

The Canadian Journal of Psychiatry

Open accessReview articleFirst published 2020

Barriers to stopping neuroleptic (antipsychotic) treatment in people with schizophrenia,psychosis or bipolar disorder

Joanna Moncrieff, Swapnil Gupta, Mark Abie Horowitz

Therapeutic Advances in Psychopharmacology

Open accessResearch articleFirst published September, 2025

Prescribing Trends for Bipolar Disorder Drugs in Alberta,Canada Between 2008 and 2021: Tendances en matière de prescription de médicaments pour le trouble bipolaire en Alberta,au Canada,entre 2008 et 2021

Samreen Shafiq, Paul Everett Ronksley, Meghan Jessica Elliott [...]

The Canadian Journal of Psychiatry

Open accessResearch articleFirst published 2026

Developing “De-stress pain,” an intervention to reduce chronic pain-related distress: Proof of concept and qualitative assessment of acceptability

Stephanie Hughes, Tamar Pincus, Adam W. A. Geraghty [...]

British Journal of Pain

Free accessResearch articleFirst published January, 2018

Poly-de-prescribing to treat polypharmacy: efficacy and safety

Doron Garfinkel

Therapeutic Advances in Drug Safety

Restricted accessReview articleFirst published April, 2024

De-Prescribing Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease: A Narrative Review

Michelle N. Schroeder, Hailee M. Sens, Shaina K. Shah

Journal of Pharmacy Practice

Restricted accessResearch articleFirst published August, 2019

Use of antipsychotics and benzodiazepines for dementia: Time for action? What will be required before global de-prescribing?

Stephen J Ralph, Anthony J Espinet

Dementia

Open accessResearch articleFirst published December, 2019

Polypharmacy among community-dwelling elderly in Singapore: Prevalence,risk factors and association with medication non-adherence

Yi Wen Tan, Sumithra Suppiah, Mary Ann C Bautista [...]

Proceedings of Singapore Healthcare

Restricted accessResearch articleFirst published May, 2020

Pharmacovigilance in Hospice/Palliative Care: De-Prescribing Combination Controlled Release Oxycodone-Naloxone

Katherine Clark, Paul G. Byrne, Jane Hunt [...]

Journal of Palliative Medicine

Open accessResearch articleFirst published 2022

De-Prescribing Proton Pump Inhibitors in Patients With End Stage Kidney Disease: A Quality Improvement Project

Daniel Czikk, Yasin Parpia, Katelyn Roberts [...]

Canadian Journal of Kidney Health and Disease

Open accessResearch articleFirst published October, 2020

The Role of the Medical School Training on Physician Opioid Prescribing Practices: Evidence from Ontario,Canada: Le rôle de la formation à la faculté de médecine à l’égard des pratiques de prescription d’opioïdes des médecins: données probantes d’Ontario,Canada

Claire de Oliveira, Tomisin Iwajomo, Tara Gomes [...]

The Canadian Journal of Psychiatry

Open accessReview articleFirst published 2020

Barriers to stopping neuroleptic (antipsychotic) treatment in people with schizophrenia,psychosis or bipolar disorder

Joanna Moncrieff, Swapnil Gupta, Mark Abie Horowitz

Therapeutic Advances in Psychopharmacology

Open accessResearch articleFirst published September, 2025

Prescribing Trends for Bipolar Disorder Drugs in Alberta,Canada Between 2008 and 2021: Tendances en matière de prescription de médicaments pour le trouble bipolaire en Alberta,au Canada,entre 2008 et 2021

Samreen Shafiq, Paul Everett Ronksley, Meghan Jessica Elliott [...]

The Canadian Journal of Psychiatry

Open accessResearch articleFirst published 2026

Developing “De-stress pain,” an intervention to reduce chronic pain-related distress: Proof of concept and qualitative assessment of acceptability

Stephanie Hughes, Tamar Pincus, Adam W. A. Geraghty [...]

British Journal of Pain